Group One Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Group One Trading’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,052	Closed	-$1.67K	–	7745
2024 Q1	$1.67K	Hold	1,052	–	–	﹤0.01%	6524
2023 Q4	$904	Buy	1,052 +600	+133%	+$527	﹤0.01%	7006
2023 Q3	$484	Buy	+452	New	+$935	﹤0.01%	7345
2022 Q4	–	Sell	-4,290	Closed	-$26.9K	–	8306
2022 Q3	$56K	Buy	+4,290	New	+$65K	﹤0.01%	5316
2021 Q2	–	Sell	-100	Closed	-$2.34K	–	8684
2021 Q1	$3K	Hold	100	–	–	﹤0.01%	7355
2020 Q4	$3K	Hold	100	–	–	﹤0.01%	6197
2020 Q3	$2K	Buy	+100	New	+$1.82K	﹤0.01%	5855

Group One Trading's NGM Position: Q2 2024 in Review

Group One Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 1,052 shares — an estimated $1.67K sold.

Group One Trading first reported a position in NGM in Q3 2020 and held it in 7 quarters. The position peaked at $56K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Group One Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Group One Trading sold 1,052 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.67K.
Group One Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Group One Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $56K in Q3 2022.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.